Annual Total Debt
$12.98 M
+$4.20 M+47.91%
December 31, 2023
Summary
- As of February 25, 2025, BRNS annual total debt is $12.98 million, with the most recent change of +$4.20 million (+47.91%) on December 31, 2023.
- During the last 3 years, BRNS annual total debt has fallen by -$33.39 million (-72.01%).
- BRNS annual total debt is now -72.01% below its all-time high of $46.36 million, reached on December 1, 2020.
Performance
BRNS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$12.67 M
+$99.00 K+0.79%
September 30, 2024
Summary
- As of February 25, 2025, BRNS quarterly total debt is $12.67 million, with the most recent change of +$99.00 thousand (+0.79%) on September 30, 2024.
- Over the past year, BRNS quarterly total debt has stayed the same.
- BRNS quarterly total debt is now -72.67% below its all-time high of $46.36 million, reached on December 1, 2020.
Performance
BRNS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
BRNS Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.9% | 0.0% |
| 3 y3 years | -72.0% | +44.4% |
| 5 y5 years | +629.9% | +698.8% |
BRNS Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +79.7% | -2.4% | +88.1% |
| 5 y | 5-year | -72.0% | +629.9% | -72.7% | -100.0% |
| alltime | all time | -72.0% | +629.9% | -72.7% | -100.0% |
Barinthus Biotherapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.67 M(+0.8%) |
| Jun 2024 | - | $12.57 M(-1.8%) |
| Mar 2024 | - | $12.81 M(-1.3%) |
| Dec 2023 | $12.98 M(+47.9%) | $12.98 M(+2.1%) |
| Sep 2023 | - | $12.70 M(+4.3%) |
| Jun 2023 | - | $12.18 M(+14.3%) |
| Mar 2023 | - | $10.65 M(+21.4%) |
| Dec 2022 | $8.77 M | $8.77 M(+6.2%) |
| Sep 2022 | - | $8.26 M(-4.1%) |
| Jun 2022 | - | $8.61 M(+27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.74 M(-6.7%) |
| Dec 2021 | $7.22 M(-84.4%) | - |
| Dec 2021 | - | $7.22 M(-11.5%) |
| Sep 2021 | - | $8.16 M(+414.7%) |
| Jun 2021 | - | $1.59 M(-2.9%) |
| Mar 2021 | - | $1.63 M(-96.5%) |
| Dec 2020 | $46.36 M(+2507.9%) | $46.36 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $1.78 M | - |
FAQ
- What is Barinthus Biotherapeutics annual total debt?
- What is the all time high annual total debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual total debt year-on-year change?
- What is Barinthus Biotherapeutics quarterly total debt?
- What is the all time high quarterly total debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly total debt year-on-year change?
What is Barinthus Biotherapeutics annual total debt?
The current annual total debt of BRNS is $12.98 M
What is the all time high annual total debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual total debt is $46.36 M
What is Barinthus Biotherapeutics annual total debt year-on-year change?
Over the past year, BRNS annual total debt has changed by +$4.20 M (+47.91%)
What is Barinthus Biotherapeutics quarterly total debt?
The current quarterly total debt of BRNS is $12.67 M
What is the all time high quarterly total debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly total debt is $46.36 M
What is Barinthus Biotherapeutics quarterly total debt year-on-year change?
Over the past year, BRNS quarterly total debt has changed by $0.00 (0.00%)